Johnson &amp; Johnson CFO Joseph J. Wolk discusses ramping up manufacturing to produce 800 million coronavirus vaccines by 2021. 'Confident' in speedy coronavirus vaccine manufacturing. $JNJ
Fox Business https://t.co/CJY1WCML2x via @YouTube